USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
TUESDAY, Aug. 22, 2023 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends prescription of preexposure prophylaxis (PrEP) with effective antiretroviral therapy for individuals at increased risk for HIV acquisition. This rec…
Learn More7.6 Percent of Global Population Had Osteoarthritis in 2020
TUESDAY, Aug. 22, 2023 (HealthDay News) — The global burden of osteoarthritis has increased since 1990 and is projected to continue increasing, according to a study published online Aug. 21 in The Lancet Rheumatology.Jaimie D. Steinmetz, Ph.D., from …
Learn MoreCancer Screening Has Provided Significant Value to U.S. Population
TUESDAY, Aug. 22, 2023 (HealthDay News) — Cancer screening has provided significant value to the U.S. population, and improved adherence would add more value, according to a study published online Aug. 7 in BMC Health Services Research.Tomas J. Phili…
Learn MoreMisleading Claims Found on Websites Selling Anti-Mullerian Hormone Tests
TUESDAY, Aug. 22, 2023 (HealthDay News) — Many misleading claims are made about the value of anti-Mullerian hormone (AMH) tests on websites that sell direct-to-consumer (DTC) AMH tests, according to a study published online Aug. 21 in JAMA Network Op…
Learn MoreACOG Guideline Addresses Hepatitis in Pregnancy
TUESDAY, Aug. 22, 2023 (HealthDay News) — In a clinical practice guideline issued by the American College of Obstetricians and Gynecologists and published online Aug. 17 in Obstetrics & Gynecology, recommendations are presented for hepatitis B and C …
Learn MoreTardive Dyskinesia Has Considerable Impact on Multiple Domains
TUESDAY, Aug. 22, 2023 (HealthDay News) — Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry.Rakesh …
Learn MoreLorazepam Has Negative Impact on Survival in Pancreatic Cancer
TUESDAY, Aug. 22, 2023 (HealthDay News) — Lorazepam stimulates fibrosis and inflammatory signaling and is associated with reduced survival in patients with pancreatic cancer, according to a study published online Aug. 17 in Clinical Cancer Research.A…
Learn MoreDupilumab Treatment Beneficial for Sleep in Atopic Dermatitis
TUESDAY, Aug. 22, 2023 (HealthDay News) — For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Au…
Learn MoreCOVID-19 Recession Resulted in ‘Baby Bump’
TUESDAY, Aug. 22, 2023 (HealthDay News) — The COVID-19 recession resulted in an overall baby bump, or increase in births, among U.S.-born mothers, according to a study published online Aug. 15 in the Proceedings of the National Academy of Sciences.Ma…
Learn MoreBudesonide Yields Durable Reduction in eGFR for IgA Nephropathy
MONDAY, Aug. 21, 2023 (HealthDay News) — For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR…
Learn More